Results 181 to 190 of about 137,395 (319)

The use of Modafinil on Methamphetamine withdrawal in mechanically ventilated patients. [PDF]

Respir Med Case Rep
Akopyan K, Engeleit A, Nguyen M, Austin A.   +3 more
europepmc   +1 more source

Effect of prebiotics on gastrointestinal symptoms and quality of life in children with intestinal failure: A pilot study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Children with intestinal failure (IF) have a substantial disease burden, with significant gastrointestinal (GI) symptoms, abnormal stool patterns and reduced health‐related quality of life (HRQOL). This study examined the effects of prebiotic supplementation on GI symptoms and HRQOL.
Rut Anne Thomassen, Janne Anita Kvammen, Beint S. Bentsen, Marianne Bratlie, Siv Kjølsrud Bøhn, Hanne Farstad, Christian Kahrs, Linh Ngo, Camilla Nybø, Camilla Sæland, Erling Tjora, Rune Rose Tronstad, Ketil Størdal, Anne Charlotte Brun, Christine Henriksen   +14 more
wiley   +1 more source

Cow's milk protein allergy with protein‐losing enteropathy under the scope

JPGN Reports, EarlyView.
ABSTRACT Objectives Cow's milk protein allergy (CMPA) is very frequent in infants. Presentation is variable, and symptoms fluctuate in intensity. Diagnosis can be challenging as it is mostly clinical. In severe cases, patients can present with anasarca secondary to protein‐losing enteropathy (PLE).
Morgane Thorens‐Borgeat, Géraldine Blanchard‐Rohner, Salim Ramadan, Jean‐Christophe Caubet, Laetitia‐Marie Petit, Valerie McLin, Anne‐Laure Rougemont   +6 more
wiley   +1 more source

Sekundarna depresija kod alkoholičara - klinički značaj [PDF]

Vojnosanitetski Pregled, 2005
Mandić-Gajić Gordana
doaj   +1 more source

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. [PDF]

Addict Sci Clin Pract
Mordal J, Juya F, Holtan L, Vederhus JK, Opheim A, Brenna IH, Enger AE, Weimand B, Solli KK, Tanum L.   +9 more
europepmc   +1 more source

Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert, David J.B. Kim, Meredith M. Miller, Sarah D. Atkinson, George B. Karkanias, Frederick E. Munschauer, Stephen P. Wanaski, Timothy M. Cunniff   +7 more
wiley   +1 more source

Biochemical Identification and Clinical Description of Medetomidine Exposure in People Who Use Fentanyl in Philadelphia, PA. [PDF]

Int J Mol Sci
Durney P, Kahoud JL, Warrick-Stone T, Montesi M, Carter M, Butt S, Mencia AM, Omoregie L, Shah M, Bloomfield M, Tomasko N, Jaffe R, Herens A, Korn WR, Alexander K, Stickle D, Goodstein D, Weinstein LC, London KS.   +18 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister, Atul T. Patel, Marta Banach, Aaron Ellenbogen, Jaroslaw Slawek, Sebastian Paus, Hyder A. Jinnah, Virgilio Evidente, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +11 more
wiley   +1 more source

A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome. [PDF]

J Pediatr Pharmacol Ther
Mamillapalli L, Lu S, Witkin J, Gavaskar R, Cheng A, McIntyre K, Aboujaoude ER, Gonzalez J, Siu A, Sturgill M.   +9 more
europepmc   +1 more source

The Persistence of Dopamine Dysregulation Syndrome after Pallidal Deep Brain Stimulation in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Dopamine dysregulation syndrome (DDS) is a debilitating complication of Parkinson's disease (PD) dopamine replacement therapy (DRT) in which patients pathologically and/or compulsively use dopaminergic drugs to treat motor symptoms. Studies examining DDS outcomes following deep brain stimulation (DBS) are limited and have focused on
Natalie David, Stewart A. Factor, Richa Tripathi, Lenora Higginbotham   +3 more
wiley   +1 more source